Novel therapeutics based on inhibiting the interaction of glycogen phosphorylase and GL-subunit of glycogen-associated protein phosphatase 1: WO2009127723

Expert Opinion on Therapeutic Patents

Volumn 20, Issue 7, 2010, Pages 969-973

  Zhang, Lei ^a   Liu, Hong ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Diabetes mellitus; Glycogen metabolism; Glycogen phosphorylase; Glycogen synthase; Hepatic glycogen targeting subunit; Protein phosphatase 1

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; HEPATIC GLYCOGEN TARGETING SUBUNIT OF GLYCOGEN ASSOCIATED PROTEIN PHOSPHATASE 1; PHOSPHONIC ACID DERIVATIVE; PHOSPHOPROTEIN PHOSPHATASE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; PHOSPHOPROTEIN PHOSPHATASE 1;

DRUG EFFICACY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATENT; PROTEIN DEPHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEM; DRUG DESIGN; ENZYMOLOGY; METABOLISM;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GLYCOGEN PHOSPHORYLASE; HUMANS; HYPOGLYCEMIC AGENTS; PATENTS AS TOPIC; PROTEIN PHOSPHATASE 1;

EID: 77953741289     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543771003781923     Document Type: Review

References (22)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
2. Henke BR, Sparks SM. Glycogen phosphorylase inhibitors. Mini Rev Med Chem 2006;6:845-857
3. Treadway JL, Mendys P, Hoover DJ. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Invest Drugs 2001;10(3):439-454
4. Oikonomakos NG, Somsák L. Advances in glycogen phosphorylase inhibitor design. Curr Opin Investig Drugs 2008;9(4):379-395
5. Baker DJ, Greenhaff PL, Macinnes A, et al. The experimental Type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Diabetes 2006;55:1855-1861
6. Cohen P. The twentieth century struggle to decipher insulin signaling. Nat Rev Mol Cell Biol 2006;7:867-873
7. Ferrera JC, Favreb C, Gomis RR, et al. Control of glycogen deposition. FEBS Lett 2003;546:127-132
8. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303
9. Roden M, Bernroider E. Hepatic glucose metabolism in humans-its role in health and disease. Best Pract Res Clin Endocrinol Metab 2003;17:365-383
10. Newgard CB, Brady MJ, O'Doherty RM, et al. Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. Diabetes 2000;49:1967-1977
11. Cohen PTW. Protein phosphatase 1-targeted in many directions. J Cell Sci 2002;115:241-256
12. Doherty MJ, Moorhead G, Morrice N, et al. Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1. FEBS Lett 1995;375:294-298
13. Armstrong CG, Doherty MJ, Cohen PTW. Identification of the separate domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 that interact with phosphorylase a, glycogen and protein phosphatase 1. Biochem J 1998;336:699-704
14. Kelsall IR, Munro S, HallyburtonI, et al. The hepatic PP1 glycogen-targeting subunit interaction with phosphorylase a can be blocked by C-terminal tyrosine deletion or an indole drug. FEBS Lett 2007;581:4749-4753
15. Kelsall IR, Rosenzweig D, Cohen PTW. Disruption of the allosteric phosphorylase a regulation of the hepatic glycogen-targeted protein phosphatase 1 improves glucose tolerance in vivo. Cell Signal 2009;21:1123-1134
16. Alemany S, Cohen P. Phosphorylase a is an allosteric inhibitor of the glycogen and microsomal forms of rat hepatic protein phosphatase-1. FEBS Lett 1986;198:194-202
17. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 2008;414:1-18
18. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998;336:19-31
19. Medical Research Council. Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same. WO2000012549; 2000
20. Zibrova D, Grempler R, Streicher R, et al. Inhibition of the interaction between protein phosphatase 1 glycogentargeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Biochem J 2008;412:359-366
21. Pautsch A, Stadler N, Wissdorf O, et al. Molecular recognition of the protein phoshpatase 1 glycogen targeting subunit by glycogen phosphorylase. J Biol Chem 2008;283(14):8913-8918
22. Patel S, Doble B, Woodgett JR. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans 2004;32:803-808